Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Researchers challenge everything we know about Alzheimer's disease with shocking new findings about amyloid beta protein's ...

Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

Believe it or not, Nyquil has not always been at the bedside of humans. We’ve relied on the incredible healing […] The post 6 ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according ...

All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging — are now required to have a ...

Once daily oral administration of blarcamesine meaningfully slowed clinical decline in early Alzheimer's disease ... a novel treatment that could be complementary or an alternative to injectable ...

Blarcamesine is an orally once daily administered small molecule for the potential treatment of patients with Alzheimer’s disease. “The EMA filing acceptance for blarcamesine to review the ...